Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Tharos who wrote (6525)	6/22/1998 10:16:00 PM
From: aknahow	Read Replies (1) \| Respond to of 17367

Interesting how your interest in nano technology lead to Scannon. Just realized where the Spanish word, Enano, comes from. What do you think of the adult trials? Is this good or bad news? Or is it a way of assuring treatment gets to adults even if Neuprex is not yet approved? I think it is good news but since XOMA failed to mention it I must say I have some doubts? Others heard Faust talk and the stock has performed poorly since the 15 th so there is room to think there are other views. BTW is adult 18 and over? I hope so so that people like the kid in Washington at least have a chance of getting treated with Neuprex. I really think the FDA should stop trying to determine if drugs are effective. They should concentrate on safety only.